Swiss pharmaceutical group Roche suspends new investments in Germany, division head says
Daniel Steiners noted that the move was driven by stringent austerity measures introduced by the German government in the healthcare sector
Daniel Steiners noted that the move was driven by stringent austerity measures introduced by the German government in the healthcare sector
No group discusses this yet. Start a discussion group and attach this story.